Brinter has launched upgraded Pneuma Triaxial Pro 'Digital Pneuma Pro' bioprinting head capable of doing microfluidic manipulations to enable more personalised tissue cell therapy and transform how diseases are treated.

Bioprinting startup Brinter has announced the launch of its entry-level Brinter Core, aiming to make 3D printing more accessible. The multi-material 3D bioprinting solution is designed to be more portable and is half the cost of its predecessor, allowing more pharmaceutical companies, hospitals, universities, and research centers to access the technology under tight budget restrictions.

Turku-based bioprinting startup Brinter has announced the successful closure of a €1.2m seed funding round led by early-stage VC Innovestor. The company will use the capital to further expand its operations internationally in Europe and the US. Brinter aims to put bioprinting within reach of every pharmaceutical company, hospital, university, and research centre.